Recent Patterns in Testicular Cancer Incidence, Mortality and Survival in the Slovak Republic with Reference to International Comparisons

REFERENCES

• Purdue MP, Devessa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer 2005;115:822–827.
   PubMed Web of Science ®Google Scholar
• Tamini R, Adami H-O. Testicular cancer, Chapter 19. In Textbook of Cancer Epidemiology, H-O Adami, D. Hunter, and D. Trichopoulos, (eds.). New York: Oxford Univ. Press Inc., 2002, 429–445. ISBN 0-19-510969-4.
   Google Scholar
• Berrino F, De Angelis R, Sant M, Rosso S, Lasota MB, Coebergh JW, Santaquilani M, the EUROCARE Working Group. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773–783.
   PubMed Web of Science ®Google Scholar
• Ondrusova M, Plesko I, Safaei-Diba Ch, Obsitnikova A, Stefanakova D, Ondrus D. Comprehensive Analysis of Incidence and Mortality of Malignant Tumours in the Slovak Republic [online]. Bratislava: National Cancer Registry of the Slovak Republic, National Health Information Center, 2007. http://www.nor-sk.org/. ISBN 978-80-89292-05-9.
   Google Scholar
• Safaei-Diba Ch, Plesko I, Frindtova V, Kopecka I, Krakovska B, Kuzma I, Miskovska V, Ondrus D, Ondrusova M, Piestanska G, Valentikova K, Wieningerova D, Zemanova M. Cancer Incidence in the Slovak Republic 2004. Bratislava: National Health Information Center, National Cancer Registry of the Slovak Republic, Cancer Research Institute SAS, 2008. ISBN 978-80-89292-04-2.
   Google Scholar
• Safaei-Diba Ch, Plesko I, Obsitnikova A, Dienerova M, Kalmancokova A, Kopecka I, Ondrusova M, Piestanska G, Valentikova K, Wieningerova D. Cancer Incidence in the Slovak Republic 2005. Bratislava: National Health Information Center, National Cancer Registry of the Slovak Republic, Cancer Research Institute SAS, 2009. ISBN 978-80-89292-15-8.
   Google Scholar
• Safaei-Diba Ch, Plesko I, Hlava P, Kalmancokova A, Kopecka I, Obsitnikova A, Ondrus D, Sieberova G, Valentikova K, Wieningerova D. Cancer Incidence in the Slovak Republic 2006. Bratislava: National Health Information Center, National Cancer Registry of the Slovak Republic, 2010. ISBN 978-80-89292-21-9.
   Google Scholar
• Hakulinen T, Abeywickrama KH. A computer program package for relative survival analysis. Comp Progr Biomed 1985;19:197–207.
   PubMedGoogle Scholar
• Brenner H, Gefeller O, Hakulinen T. Period analysis for up-to-date cancer survival data: theory, empirical evaluation, computational realization and applications. Eur J Cancer 2004;40:326– 335.
   PubMed Web of Science ®Google Scholar
• Manecksha RP, Fitzpatrick JM. Epidemiology of testicular cancer. BJU Int 2009;104:1329–1333.
   PubMed Web of Science ®Google Scholar
• Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer. An overview. Int J Cancer 2005;116:331– 339.
   PubMed Web of Science ®Google Scholar
• Dusek L, Abrahamova J, Lakomy R, Vyzula R, Koptikova J, Pavlik T, Muzik J, Klimes D. Multivariate analysis of risk factors for testicular cancer: a hospital-based case-control study in the Czech Republic. Neoplasma 2008;55:356–368.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. Lyon: IARC CancerBase No. 10 [Internet]. IARC, 2010. Available from: http://globocan.iarc.fr/
   Google Scholar
• Rosen A, Jayram G, Drazer M, Eggener SE. Global trends in testicular cancer incidence and mortality. Eur Urol 2011;60:374– 379.
   PubMed Web of Science ®Google Scholar
• Chia VM, Quraishi SM, Devesa SS, Purdue MP, Cook MB, McGlynn KA. International trends in the incidence of testicular cancer, 1973–2002. Cancer Epidemiol Biomarkers Prev 2010;19:1151–1159.
   PubMed Web of Science ®Google Scholar
• Huyghe E, Plante P, Thonneau PF. Testicular cancer variations in time and space in Europe. Eur Urol 2007;51:621–628.
   PubMed Web of Science ®Google Scholar
• Sant M, Aareleid T, Artioli ME, Berrino F, Coebergh JW, Colonna M, Forman D, Hedelin G, Rachtan J, Lutz JM, Otter R, Raverdy N, Plesko I, Primic M-Z, Tagliabue G. Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study. Eur J Cancer 2007;43:585–592.
   PubMed Web of Science ®Google Scholar
• Dusek L, Muzik J, Kubasek M, Koptikova J, Zaloudik J, Vyzula R. Epidemiology of Mmalignant Tumours in the Czech Republic [online]. Brno: Masaryk University, 2005. [cit. 2011-07-20]. On-line available: http:www.svod.cz. ISSN 1802-8861.
   Google Scholar
• La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, Levi F. Cancer mortality in Europe, 2000–2004, and a review of trends since 1975. Ann Oncol 2010;21:1323–1360.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Bertuccio P, Chatenoud L, Negri E, La Vecchia C, Levi F. Trends in mortality from urologic cancers in Europe, 1970–2008. Eur Urol 2011;60:1–15.
   PubMed Web of Science ®Google Scholar
• Bray F, Richiardi L, Ekbom A, Pukkala E, Cuninkova M, Møller H. Trends in testicular cancer incidence and mortality in 22 European coutries: continuing increases in incidence and declines in mortality. Int J Cancer 2006;118:3099–3111.
   PubMed Web of Science ®Google Scholar
• Møller H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 1993;23:8–13.
   PubMed Web of Science ®Google Scholar
• Juska A, Ulys A, Kairevice L, Smailyte G, Stankevicius E, Janciauskiene R, Jievaltas M. Survial of patients with testicular cancer in Lithuania during 1999–2002. Medicina 2011;47:52–56.
   PubMedGoogle Scholar
• Aareleid T, Gondos A, Brenner H, Pokker H, Leppik K, Mägi M. Testicular cancer survival in Estonia; improving but still relatively low. Acta Oncol 2011;50:99–105.
   PubMed Web of Science ®Google Scholar
• Passos-Coelho JL, Castro Ribeiro M, Santos E, Sousa Pontes C, Brito B, Miranda AC. Suboptimal survival of male germ-cell tumors in southern Portugal–a population-based retrospective study for cases diagnosed in 1999–2000. Ann Oncol 2011;22:1215–1220.
   PubMed Web of Science ®Google Scholar
• Bray F, Klint Å, Gislum M, Hakulinen M, Engholm G, Tryggvadottir L, Storm HH. Trends in survival of patients with male genital cancers in the Niordic countries 1964–2003 followed up until the end of 2006. Acta Oncol 2010;49:644–654.
   PubMed Web of Science ®Google Scholar
• Sarma AV, McLaughlin JC, Schottenfeld D. Testicular cancer. Chapter 60, In Cancer Epidemiology and Prevention, 3rd edition. D Schottenfeld, and JF Fraumeni Jr (eds.). New York: Oxford University Press, 2006, 1151-1165. ISBN 978-0-19-514961-6.
   Google Scholar
• Biggs ML, Schwartz SM. Differences in testis cancer survival by race and ethnicity: a population-based study, 1973–1999 (United States). Cancer Causes Control 2004;15:437–444.
   PubMed Web of Science ®Google Scholar
• Peckham MJ, McElwain TJ, Barrett A, Hendry WF. Combined management of malignant teratoma of the testis. Lancet 1979;2:267–270.
   PubMed Web of Science ®Google Scholar
• Cavalli F, Monfardini S, Pizzocaro G. Report on the international workshop on staging and treatment of testicular cancer. Eur J Cancer 1980;6:1367–1372.
   Google Scholar